Riskpilot← Back to searchSign inGet full accessBÆRUM ØYEKLINIKK AS
ASActiveOrg 891791682Sandvika Storsenter Helsetorget 4ETG, 1337 SandvikaMedical specialists activities · NACE 8622Est. 20075 employees
Revenue 2024
NOK 3,6M
0% vs 2023
EBITDA margin
1.9%
+190% vs 2023
Equity ratio
54.0%
Financial strength
Net profit 2024
NOK -60K
+72% vs 2023
| Revenue | NOK 3,6M | +0% |
| EBITDA | NOK 68K | +190% |
| Net profit | NOK -60K | +72% |
| Total assets | NOK 1,9M | -3% |
| Equity | NOK 1M | -6% |
| Employees | 5 | — |
Legal name
BÆRUM ØYEKLINIKK AS
Org number
891791682
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
17. oktober 2007
Share capital
NOK 150 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder og styrets leder i fellesskap.
Company purpose
Øyenlegekontor, investeringer i driftsmidler og verdipapirer, samt deltakelse i andre selskaper.
Address
Sandvika Storsenter Helsetorget 4ETG, 1337 Sandvika
Phone
+4767575780
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 697 | 3 991 | 3 600 | 3 600 | 3 600 |
| Staff expenses | −945 | −1 454 | −1 836 | −1 721 | −1 475 |
| EBITDA | 1 139 | 841 | −55 | −75 | 68 |
| Depreciation & amort. | −138 | −91 | −144 | −144 | −159 |
| EBIT | 1 002 | 750 | −200 | −220 | −91 |
| Net financials | 2 | 2 | 3 | 11 | 31 |
| Profit before tax | 1 004 | 753 | −197 | −209 | −60 |
| Tax | 116 | 166 | −12 | −0 | −0 |
| Net profit | 888 | 587 | −185 | −209 | −60 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 118 | 2 116 | 1 886 | 1 952 | 1 885 |
| Equity | 185 | 1 472 | 1 287 | 1 078 | 1 018 |
| Long-term debt | 0 | 187 | 175 | 175 | 302 |
| Short-term debt | 933 | 457 | 425 | 700 | 566 |
| Total debt | 933 | 644 | 600 | 875 | 867 |
EBITDA margin
1.9%
This company
15.8%
Market median
-88% vs market
20202024
Equity ratio
54.0%
This company
38.2%
Market median
+41% vs market
20202024
Return on equity
-5.8%
This company
18.4%
Market median
-132% vs market
20202024
Net profit margin
-1.7%
This company
8.1%
Market median
-121% vs market
20202024
Asset turnover
1.91×
This company
1.12×
Market median
+71% vs market
20202024
Debt / equity
0.85×
This company
0.62×
Market median
+37% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KU Chief Executive Officer | Chief Executive Officer | 2016 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Chairman | 2022 | |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
I Care As
BÆRUM ØYEKLINIKK AS Board members of BÆRUM ØYEKLINIKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kjetil Unger Norveel | Chief Executive Officer | 0 companies |
| Jan Erik Jakobsen | Board of Directors | 0 companies |
| Tor Øivind Grøndahl | Chairman | 0 companies |